Phase 3 Study of First-Line Pembrolizumab +/- Vibostolimab (anti-TIGIT) in Patients With PD-L1-Positive Metastatic NSCLC

Hellmann M. D., Cho B. C., Juergens R., Cheng Y., De Castro G., Erman M., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.16, no.10, 2021 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 16 Issue: 10
• Publication Date: 2021
• Journal Name: JOURNAL OF THORACIC ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
• Keywords: metastatic non-small-cell lung cancer, Pembrolizumab, vibostolimab
• Hacettepe University Affiliated: Yes